Sasol Limited:企業の戦略・SWOT・財務情報

◆英語タイトル:Sasol Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C8972
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:南アフリカ
◆産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Sasol Limited – Strategy, SWOT and Corporate Finance Report
Summary

Sasol Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sasol Limited (Sasol or the company’) is a conglomerate company, involved in integrated energy and chemical business. The company’s products portfolio comprises olefins and surfactants, cleaners and degreasers, industrial lubricants, polypropylene, chlor-alkaline chemicals, explosives, and waxes. It also produces a broad range of products such as liquid fuels, chemicals, and low-carbon electricity. The company also develops and commercializes technologies. Through exploration and production, the company provides low-cost feedstock, coal, through mining, and oil, gas and condensate. It operation comprises a wide network of upstream, regional operating hubs, and customer-facing strategic business units. The company operates in South Africa, Europe, Asia-Pacific and the Americas. Sasol is headquartered in Johannesburg, Gauteng, South Africa.

Scope

- Detailed information on Sasol Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sasol Limited in the form of a SWOT analysis
- An in-depth view of the business model of Sasol Limited including a breakdown and examination of key business segments
- Intelligence on Sasol Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sasol Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sasol Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sasol Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Sasol Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Sasol Limited: Company Overview 9
Sasol Limited: Overview and Key Facts 9
Sasol Limited: Overview 9
Sasol Limited: Key Facts 9
Sasol Limited: Key Employees 11
Sasol Limited: Key Employee Biographies 13
Sasol Limited: Major Products and Services 23
Sasol Limited: Company History 24
Sasol Limited: Management Statement 29
Sasol Limited: Locations and Subsidiaries 33
Sasol Limited: Key Competitors 34
Sasol Limited: Company Analysis 35
Sasol Limited: Business Description 35
Sasol Limited: SWOT Analysis 37
Sasol Limited: SWOT Overview 37
Sasol Limited: Strengths 37
Sasol Limited: Weaknesses 38
Sasol Limited: Opportunities 38
Sasol Limited: Threats 40
Sasol Limited: Corporate Financial Deals Activity 42
Sasol Limited: Financial Deals Overview 42
Sasol Limited: Top Deals 2014 – 2018YTD* 44
Sasol Limited: Advisors 45
Sasol Limited: Top Legal Advisors 45
Sasol Limited: Top Financial Advisors 45
Sasol Limited: Capital Raising 46
Sasol Limited: Divestments 47
Sasol Limited: Recent Developments 48
Sasol Limited: News and Events Summary 48
Sasol Limited: Business Expansion 52
Sasol Limited: Contracts 52
Sasol Limited: Financial Performance 54
Sasol Limited: Strategy and Operations 55
Appendix 56
Contact Us 56
Methodology 56
About MarketLine 57

List of Tables
Table 1: Sasol Limited: Key Facts
Table 2: Sasol Limited: Key Employees
Table 3: Sasol Limited: Company History
Table 4: Sasol Limited: Locations and Subsidiaries
Table 5: Sasol Limited: Key Competitors
Table 6: Sasol Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Sasol Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Sasol Limited: Top Deals 2014 - 2018YTD*
Table 9: Sasol Limited: Legal Advisor Ranking by Value (US$m)
Table 10: Sasol Limited: Financial Advisor Ranking by Value (US$m)
Table 11: Sasol Limited: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 12: Sasol Limited: Capital Raising by Deal Type (2014 - YTD*2018)
Table 13: Sasol Limited: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 14: Sasol Limited: Divestments by Geography (2014 - YTD*2018)
Table 15: Sasol Limited: News and Events Summary
Table 16: Sasol Limited: Business Expansion
Table 17: Sasol Limited: Contracts
Table 18: Sasol Limited: Financial Performance
Table 19: Sasol Limited: Strategy and Operations

List of Figures
Figure 1: Sasol Limited: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Sasol Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Sasol Limited: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 4: Sasol Limited: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 5: Sasol Limited: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 6: Sasol Limited: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Sasol Limited:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Joslin Diabetes Center-製薬・医療分野:企業M&A・提携分析
    Summary Joslin Diabetes Center (Joslin) is a healthcare service provider that provides diabetes treatment, research and education services. The centers services include weight management programs, pregnancy program, eye care, diabetes prevention, research, diabetes patient education, adult diabetic …
  • Power Climber Wind:企業の戦略的SWOT分析
    Power Climber Wind - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • NextPharma Technologies Holding Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary NextPharma Technologies Holding Ltd (NextPharma) is a contract development and manufacturing organization that provides pharmaceutical products and services. The company offers wide range of services such as pharmaceutical development, analytical services, clinical trials services, commercia …
  • PTT Exploration and Production Public Co Ltd (PTTEP):企業の財務・戦略的SWOT分析
    PTT Exploration and Production Public Co Ltd (PTTEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Golden Star Resources Ltd:企業の戦略・SWOT・財務分析
    Golden Star Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Golden Star Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Keryx Biopharmaceuticals Inc (KERX)-製薬・医療分野:企業M&A・提携分析
    Summary Keryx Biopharmaceuticals Inc (Keryx) develops and commercializes new therapies for the treatment of renal disease. The company’s lead product Auryxia (ferric citrate) is an FDA approved oral, absorbable iron-based phosphate binder, which helps lower the amount of phosphate in human blood. Au …
  • Shinkin Central Bank:企業の戦略・SWOT・財務情報
    Shinkin Central Bank - Strategy, SWOT and Corporate Finance Report Summary Shinkin Central Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Kootenai Electric Cooperative Inc:企業の戦略的SWOT分析
    Kootenai Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • LIXIL Group Corporation:企業の戦略・SWOT・財務分析
    LIXIL Group Corporation - Strategy, SWOT and Corporate Finance Report Summary LIXIL Group Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Keepmoat Ltd:企業の戦略的SWOT分析
    Keepmoat Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Univision Communications Inc.:企業の戦略的SWOT分析
    Univision Communications Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Progenics Pharmaceuticals Inc (PGNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Progenics Pharmaceuticals Inc (Progenics) is a late-stage biopharmaceutical company that focuses on developing medicines and products for the treatment of cancer and related conditions. Its only commercial product, Relistor, is used for the treatment of opioid-induced constipation. The compa …
  • Jardine Engineering Corporation, Limited:企業の戦略・SWOT・財務情報
    Jardine Engineering Corporation, Limited - Strategy, SWOT and Corporate Finance Report Summary Jardine Engineering Corporation, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Stantec Inc (STN)-エネルギー分野:企業M&A・提携分析
    Summary Stantec Inc. (Stantec) is a consulting services company offering architectural, engineering, and environmental services. Its service portfolio includes architecture and interior design, building engineering, community design services, geomatics, geotechnical engineering, landscape architectu …
  • Securitas AB:企業の戦略・SWOT・財務情報
    Securitas AB - Strategy, SWOT and Corporate Finance Report Summary Securitas AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • The Vanguard Group Inc:企業の戦略的SWOT分析
    The Vanguard Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • The Hospital for Sick Children-製薬・医療分野:企業M&A・提携分析
    Summary The Hospital for Sick Children (SickKids) is a healthcare service provider that offers children care services. The hospital offers programs and services including resources, tele-medicine, accommodations, child life, creative arts therapy, child and family-centered care; health records inqui …
  • DEINOVE SA (ALDEI):製薬・医療:M&Aディール及び事業提携情報
    Summary Deinove SA (Deinove) is a biotech company that discovers, develops and produces compounds. The company combines its biological assets and its metabolic engineering technology in three fields of application including healthcare, nutrition and cosmetics. Its healthcare application provides res …
  • ABT Molecular Imaging Inc:医療機器:M&Aディール及び事業提携情報
    Summary ABT Molecular Imaging Inc (ABT) is a medical imaging company engaged in the development of biomarker generator systems and related accessories. Its technology platform BG-75, a biomarker generator produces unit doses of molecular imaging drugs for positron emission tomography (PET) at the po …
  • HL Global Enterprises Limited:企業の戦略・SWOT・財務情報
    HL Global Enterprises Limited - Strategy, SWOT and Corporate Finance Report Summary HL Global Enterprises Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆